As chairman of the Court of the University of Edinburgh between 2003 and 2006 I was in a position to know something that Sir Ken Murray – he was Ken, not Kenneth to his vast array of friends in the scientific community worldwide – and his wife, Lady Noreen, did not want generally known: that they had donated over £12m to their university. This fund accrued from the patent rights of Murray's work, which spearheaded the fight against hepatitis. Murray and his Edinburgh team found a way to identify the hepatitis B virus, which seriously damages the liver, and developed a vaccine against it. He was also a co-founder of the biotech company Biogen, which patented the vaccine.














